NDT @ndt-era.bsky.social · 16/03/2026Urinary dipstick findings and UTI risk with SGLT2 inhibitors: a post hoc analysis of the CANVAS and CREDENCE trials doi.org/10.1093/ndt/... 022
NDT @ndt-era.bsky.social · 13/03/2026Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications doi.org/10.1093/ndt/...doi.orgAnti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implicationsABSTRACT. The discovery of circulating autoantibodies targeting slit diaphragm proteins—particularly nephrin, podocin and Kirrel1—has redefined the pathoge 010
NDT @ndt-era.bsky.social · 13/03/2026Evolving strategies for early diagnosis, proactive prevention and treatment of CKD doi.org/10.1093/ndt/...doi.orgEvolving strategies for early diagnosis, proactive prevention and treatment of CKDABSTRACT. Chronic kidney disease (CKD) is among the fastest growing global causes of death, forecasted to become the third leading cause of death in Wester 000
NDT @ndt-era.bsky.social · 10/03/2026Management of monoclonal gammopathy of renal significance: treatment standard doi.org/10.1093/ndt/...doi.orgManagement of monoclonal gammopathy of renal significance: treatment standardABSTRACT. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B cell or plasma cell proliferative disorders that cause ki 042
NDT @ndt-era.bsky.social · 10/03/2026😍 Check out the new March issue of NDT! academic.oup.com/ndt/issueacademic.oup.comIssues | Nephrology Dialysis Transplantation | Oxford AcademicAn official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol... 000
NDT @ndt-era.bsky.social · 02/03/2026Effects of microplastics and nanoplastics on the kidneys doi.org/10.1093/ndt/...doi.orgEffects of Microplastics and Nanoplastics on the KidneysAbstract. Plastics are hydrophobic carbon polymers with a half-life of approximately 500 years. The widespread production and environmental accumulation of 020
NDT @ndt-era.bsky.social · 02/03/2026The updated global burden of chronic kidney disease: one death every 20 seconds doi.org/10.1093/ndt/...doi.orgThe updated global burden of chronic kidney disease: one death every 20 secondsAbstract. In 2024, Global Burden of Disease (GBD) updated the forecast of global cause-specific age-standardized death rates. Chronic kidney disease (CKD) 010
NDT @ndt-era.bsky.social · 26/02/2026What do clinical trials teach us about the pathophysiology of human IgA nephropathy? 🆓 doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 05/02/2026Oil supplementation and cardiovascular mortality in the dialysis population doi.org/10.1093/ndt/... 010
NDT @ndt-era.bsky.social · 27/01/2026Risk-based referral model to nephrologist specialist care in Stockholm doi.org/10.1093/ndt/... 012
NDT @ndt-era.bsky.social · 16/01/2026The multiple autoantibodies in anti-GBM disease doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 14/01/2026😍Did you already discover the NDT kidney art gallery? era-online.org/ndt-kidney-a... 🤩Check it out and send us one of your own kidney images! 021
NDT @ndt-era.bsky.social · 13/01/2026🤩 Check out the new January issue of NDT! academic.oup.com/ndt/issue/41/1academic.oup.comVolume 41 Issue 1 | Nephrology Dialysis Transplantation | Oxford AcademicAn official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol... 000
NDT @ndt-era.bsky.social · 13/01/2026Anti-glomerular basement membrane disease—treatment standard doi.org/10.1093/ndt/...doi.orgAnti-glomerular basement membrane disease—treatment standardABSTRACT. We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management 000
NDT @ndt-era.bsky.social · 12/12/2025Membranous nephropathy treatment standard doi.org/10.1093/ndt/...doi.orgMembranous nephropathy treatment standardABSTRACT. Membranous nephropathy (MN) is characterized by deposition of immune complexes leading to thickening of glomerular basement membranes. Over time, 000
NDT @ndt-era.bsky.social · 11/12/2025How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA doi.org/10.1093/ndt/...doi.orgHow to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERAABSTRACT. The interrelated pandemics of obesity and type 2 diabetes mellitus (T2DM) are fuelling an increase in the prevalence of chronic kidney disease (C 020
NDT @ndt-era.bsky.social · 11/12/2025When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice doi.org/10.1093/ndt/...doi.orgWhen impact trials are not feasible: alternatives to study the impact of prediction models on clinical practiceABSTRACT. Patients with kidney disease have an uncertain future, with prognosis varying greatly per patient. To get a better idea of what the future holds 000
NDT @ndt-era.bsky.social · 10/12/2025How should we best manage the consequences of nephron loss in IgAN? doi.org/10.1093/ndt/...doi.orgHow should we best manage the consequences of nephron loss in IgAN?Jackson Kim, Fahmeedah Kamal, Brittany Yeung, Richard Lafayette; How should we best manage the consequences of nephron loss in IgAN?, Nephrology Dialysis T 000
NDT @ndt-era.bsky.social · 08/12/2025Disease modification in IgA nephropathy doi.org/10.1093/ndt/...doi.orgDisease Modification in Immunoglobulin A NephropathyJonathan Barratt; Disease Modification in Immunoglobulin A Nephropathy, Nephrology Dialysis Transplantation, , gfaf259, https://doi.org/10.1093/ndt/gfaf259 011
NDT @ndt-era.bsky.social · 05/12/2025BK Polyomavirus-associated nephropathy – diagnostic and treatment standard 🆓 doi.org/10.1093/ndt/...doi.orgBK Polyomavirus-associated nephropathy – diagnostic and treatment standardABSTRACT. BK polyomavirus (BKPyV) is recognized as a significant viral complication of kidney transplantation. Prompt immunosuppression reduction reduces e 002
NDT @ndt-era.bsky.social · 04/12/2025Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050 doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 04/12/2025Cardiovascular involvement in ANCA-associated vasculitis doi.org/10.1093/ndt/...doi.orgCardiovascular involvement in ANCA-associated vasculitisABSTRACT. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic necrotizing vasculitis with significant cardiovascular invo 000
NDT @ndt-era.bsky.social · 03/12/2025Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds doi.org/10.1093/ndt/... 100
NDT @ndt-era.bsky.social · 02/12/2025The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 02/12/2025Effectiveness and safety of finerenone in IgA nephropathy patients doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 01/12/2025Management of monoclonal gammopathy of renal significance: treatment standard doi.org/10.1093/ndt/...doi.orgManagement of monoclonal gammopathy of renal significance: treatment standardAbstract. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B-cell or plasma cell proliferative disorders that cause ki 001
NDT @ndt-era.bsky.social · 28/11/2025Kidney disease after hematopoietic stem cell transplant —treatment standard doi.org/10.1093/ndt/...doi.orgKidney disease after hematopoietic stem cell transplant—treatment standardABSTRACT. Hematopoietic stem cell transplant (HSCT) is a well-established procedure for malignant and nonmalignant conditions. Despite its therapeutic bene 000
NDT @ndt-era.bsky.social · 26/11/2025🤩Check out the new December issue of NDT! academic.oup.com/ndt/issue/40... 000
Reposted by NDTUK Kidney Association @ukkidney.org · 24/11/2025Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome. 📄: ow.ly/L9HK50XqqqT 033
NDT @ndt-era.bsky.social · 25/11/2025Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents doi.org/10.1093/ndt/...doi.orgNephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite AgentsAbstract. Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventiona 001
NDT @ndt-era.bsky.social · 24/11/2025Trends in nephrology: from reducing proteinuria with steroids to curing glomerulonephritis doi.org/10.1093/ndt/...doi.orgTrends in Nephrology: From reducing proteinuria with steroids to curing glomerulonephritisGlomerulonephritis (GN) is a subgroup of kidney disorders characterized by inflammation and injury at the glomerular filtration barrier manifesting as hype 000
NDT @ndt-era.bsky.social · 21/11/2025Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox doi.org/10.1093/ndt/...doi.orgBody roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradoxAbstractBackground. Body roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortal 000
NDT @ndt-era.bsky.social · 20/11/2025Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction doi.org/10.1093/ndt/...doi.orgCardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correctionSodium/glucose co-transporter 2 inhibitors (SGLT2i) slow the progression of chronic kidney disease (CKD) and heart failure without the risk of concomitant 022
NDT @ndt-era.bsky.social · 19/11/2025C3G and Ig-MPGN: treatment standard doi.org/10.1093/ndt/...doi.orgC3G and Ig-MPGN—treatment standardABSTRACT. Among the broad spectrum of membranoproliferative glomerulonephritis (MPGN), immunofluorescence distinguishes C3 glomerulopathy (C3G), with predo 021
NDT @ndt-era.bsky.social · 18/11/2025👉Trends in nephrology: Cardiovascular Kidney-Metabolic syndrome 🆓 doi.org/10.1093/ndt/... 140
NDT @ndt-era.bsky.social · 17/11/2025Global epidemiology of kidney cancer doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 17/11/2025Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 14/11/2025Where is the eye of the storm of eGFR formulas? doi.org/10.1093/ndt/... The EKFC eGFR equation represents an evolution rather than a revolution, offering better performance and flexibility for broader clinical implementation in Europe 020
Reposted by NDTAIN/Sandipan Shringi @nephrosage.bsky.social · 11/11/2025Life support in hemodialysis emergencies—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.socialacademic.oup.comLife support in hemodialysis emergencies—treatment standardABSTRACT. Hemodialysis removes uremic toxins and excess water and sodium from the blood of patients with kidney failure. For the last 60 years, this techni 041
Reposted by NDTAIN/Sandipan Shringi @nephrosage.bsky.social · 12/11/2025A novel system to continuously estimate intradialytic blood pressure in real time More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.socialacademic.oup.comA novel system to continuously estimate intradialytic blood pressure in real timeABSTRACTBackground. Intradialytic hypotension (IDH) is a common complication of haemodialysis that is associated with adverse patient outcomes. We have dev 042
Reposted by NDTAIN/Sandipan Shringi @nephrosage.bsky.social · 13/11/2025High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort More info:https://academic.oup.com/ndt/article/40/11/2091/8122110 @ndt-era.bsky.social, @hjanders.bsky.socialacademic.oup.comHigh measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohortABSTRACTBackground. High glomerular filtration rate (GFR) is generally regarded as beneficial but has been associated with cardiovascular disease (CVD) and 022
Reposted by NDTSwapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 13/11/2025Interesting molecule - Troxerutin as an osmotic agent for PD academic.oup.com/ndt/advance-... in @ndt-era.bsky.social It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru... #PDSky #NephSky 0103
NDT @ndt-era.bsky.social · 24/10/2025Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index doi.org/10.1093/ndt/... 010
NDT @ndt-era.bsky.social · 21/10/2025Temporal trends in the treatment of relapsing minimal change podocytopathy — a binational cohort study doi.org/10.1093/ndt/... 030
NDT @ndt-era.bsky.social · 21/10/2025Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry doi.org/10.1093/ndt/... 000
NDT @ndt-era.bsky.social · 16/10/2025GLP-1-based therapeutics for cardiorenal protection in metabolic diseases doi.org/10.1093/ndt/... 020
NDT @ndt-era.bsky.social · 10/10/2025Treatment standard: CKD in the geriatric patient doi.org/10.1093/ndt/... 010
NDT @ndt-era.bsky.social · 09/10/2025Complement activation in kidney transplantation doi.org/10.1093/ndt/... 000
Reposted by NDTHans-Joachim Anders @hjanders.bsky.social · 28/09/2025Now open access in @ndt-era.bsky.social Prevalence of Strongyloides stercoralis in HD pts in Vienna 🧐Implementation of targeted screening for S. stercoralis should be considered in pre-KTX protocols in Europe. ▶️ academic.oup.com/ndt/article/... 021